Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Pancreatic Ductal × Capecitabine × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 36 Stomach Neoplasms 17 Rectal Neoplasms 14 Colorectal Neoplasms 13 Triple Negative Breast Neoplasms 10 Neoplasm Metastasis 10 Adenocarcinoma Of Esophagus 7 Esophageal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Nasopharyngeal Carcinoma 5 Colonic Neoplasms 5 Adenocarcinoma 5 Recurrence 4 Neoplasms 4 Cholangiocarcinoma 4 Locally Advanced Rectal Cancer 3 Colorectal Cancer Metastatic 3 Brain Neoplasms 3 Anus Neoplasms 3 Somatostatinoma 2 Pathologic Complete Response 2 HER2-positive Gastric Cancer 2 Gallbladder Neoplasms 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Advanced Solid Tumour 2 Solid Cancer 1 Resectable Colon Cancer 1 Rectal Neoplasms Malignant 1 Pancreatic Neoplasms 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 Cetuximab 3 Bevacizumab 3 pembrolizumab 2 Pemetrexed 2 Paclitaxel 2 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Cisplatin 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 relacorilant 1 Long Interspersed Nucleotide Elements 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡